Article
A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment.
Neurobiology of disease - 1 Jul 2008
Liu Li, Orozco Ian J, Planel Emmanuel, Wen Yi, Bretteville Alexis, Krishnamurthy Pavan, Wang Lili, Herman Mathieu, Figueroa Helen, Yu W Haung, Arancio Ottavio, Duff Karen
Abstract excerpt
In the last decade, multiple lines of transgenic APP overexpressing mice have been created that recapitulate certain aspects of Alzheimer's disease (AD). However, none of the previously reported transgenic APP overexpressing rat models developed AD-like beta-amyloid (Abeta) deposits, or age-related learning and memory deficits. In the present study, we have characterized a transgenic rat model overexpressing...
Topics
- Alzheimer Disease
- Amyloid beta-Protein Precursor
- Animals
- Animals, Genetically Modified
- Brain
- Cognition Disorders
- Disease Models, Animal
- Enzyme-Linked Immunosorbent Assay
- Excitatory Postsynaptic Potentials
